Newsletter | July 2024

Predoctoral Fellowships: $30,000 a year for up to two years

Postdoctoral Fellowships: $60,000 a year for up to two years

Faculty Starter Grants: $100,000 for one year

Before You Apply: Review Free Application Resources

PhF provides webinars, blogs, and infographics with advice on writing a standout application. Check out the resources below and find more on our website.

Dr. David Veenstra, a professor in the Comparative Health Outcomes, Policy & Economics Institute at the University of Washington, discusses how to write a clear, compelling, and realistic aims page. Watch the webinar or read the summary.

Hear advice from Dr. Peter J. Neumann, director of the Center for the Evaluation of Value and Risk in Health at Tufts Medical Center, on writing a successful grant application. Watch the webinar or read the summary.

Hear directly from our 2024 award recipients about their research and career paths.

Dr. Nokomis Ramos-Gonzalez: Designing New Opioids With Fewer Harmful Effects

Xiyin Wang: Targeting a Shared Vulnerability in Breast and Ovarian Cancer

Emilie Duchesneau, PhD (PhF24), of Wake Forest University Health Sciences presented her work "Ten-year cognition transitions in older cancer survivors in the National Health and Aging Trends Study (NHATS)" at the 2024 Society for Epidemiologic Research Annual Meeting in June.

Rhashanda Haywood (PhF23) of the University of Maryland, Eastern Shore, won 3rd place in the Drug Discovery and Development Division’s poster competition for graduate and post-baccalaureate students at the 2024 American Society for Pharmacology and Experimental Therapeutics (ASPET) Conference in May.

Wesam Ismail (PhF24) of the University of Iowa won the Audience Choice Award at the 20th Midwest Social and Administrative Pharmacy Conference for his presentation of his Foundation-funded dissertation work, “Risk of infections with induction therapy among pediatric kidney transplant patients: A comparative safety study.”

Ding Quan Ng (PhF23) of the University of California, Irvine, presented his Foundation-funded work, "Value assessment of acupuncture for treating cancer pain: a real-world claims database analysis," at the Multinational Association of Supportive Care in Cancer (MASCC) annual meeting in June.

Jacqueline Plau, PhD (PhF23), started a postdoctoral position at the University Hospital Zürich in Switzerland, where she is working with lymphedema patient samples toward developing new drug treatments.

Marek Zorawski (PhF24) of Duke University presented his Foundation-funded research during a poster session at the RNA Society annual meeting in May.

Congrats to these Foundation-funded researchers on their recent work.

**Indicates research directly supported by a PhRMA Foundation award.

**Utilization of Low- and High-Value Health Care by Individuals With and Without Cognitive Impairment, American Journal of Managed Care

Douglas Barthold, PhD (PhF21), University of Washington

Longitudinal trajectories of a claims-based frailty measure during adjuvant chemotherapy in women with stage I-III breast cancer, The Oncologist

Emilie Duchesneau, PhD (PhF24), Wake Forest University

Performance of a claims-based frailty proxy using varying frailty ascertainment lookback windows, Medical Care

Emilie Duchesneau, PhD (PhF24), Wake Forest University

**Mapping medically relevant RNA isoform diversity in the aged human frontal cortex with deep long-read RNA-seq, Nature Biotechnology

Mark T. W. Ebbert, PhD (PhF17), University of Kentucky

Kidney transplantation in patients with tuberous sclerosis complex, Pediatric Transplantation

Wesam Ismail (PhF24), University of Iowa

Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023, International Journal of Pharmaceutics: X

Tze Ning Hiew, PhD (PhF24), University of Iowa & Dana E. Moseson, PhD (PhF21), Pfizer

**Novel psychoplastogen DM506 reduces cue-induced heroin-seeking and inhibits tonic GABA currents in the Prelimbic Cortex, Neurochemistry International

Swarup Mitra, PhD (PhF23), Oklahoma State University Center for Health Sciences

**Discovery of 3-((4-Benzylpyridin-2-yl)amino)benzamides as Potent GPR52 G Protein-Biased Agonists, Journal of Medicinal Chemistry

Ryan Murphy (PhF22), University of Texas Medical Branch, Galveston

**Orphan GPR52 as an emerging neurotherapeutic target, Drug Discovery Today

Ryan Murphy (PhF22), University of Texas Medical Branch, Galveston

**Can Generalized Cost-effectiveness Analysis Leverage Meaningful Use of Novel Value Elements in Pharmacoeconomics to Inform Medicare Drug Price Negotiation? Value in Health

William Padula, PhD (PhF22/23), University of Southern California

Enhancing in vivo cell and tissue targeting by modulation of polymer nanoparticles and macrophage decoys, Nature Communications

Alexandra S. Piotrowski-Daspit (PhF24), University of Michigan

**Infant and adult human intestinal enteroids are morphologically and functionally distinct, mBio

Sasirekha Ramani, PhD (PhF20), Baylor College of Medicine

**Uncover spatially informed variations for single-cell spatial transcriptomics with STew, Bioinformatics Advances

Fan Zhang, PhD (PhF22), University of Colorado

**Feasibility of Observing Cerebrovascular Disease Phenotypes with Smartphone Monitoring: Study Design Considerations for Real-World Studies, Sensors

Stephanie Zawada (PhF23), Mayo Clinic

**Accelerometer‐Measured Behavior Patterns in Incident Cerebrovascular Disease: Insights for Preventative Monitoring From the UK Biobank, Journal of the American Heart Association

Stephanie Zawada (PhF23), Mayo Clinic

Did someone forward this to you?

Subscribe to get updates and funding announcements directly in your inbox.

www.phrmafoundation.org